Cited by 910Schizophrenia research and treatmentPsychiatric care and mental health servicesMental Health and Psychiatry

The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.

Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations

Lehman, A. F., Steinwachs, D. M., The Co-Investigators of the PORT Project·1998·Schizophrenia Bulletin

DOI 10.1093/oxfordjournals.schbul.a033302

Open this paper in CoChat — free account

Abstract

Beginning in 1992, the Agency for Health Care Policy and Research and the National Institute of Mental Health funded the Schizophrenia Patient Outcomes Research Team (PORT) to develop and disseminate recommendations for the treatment of schizophrenia based on existing scientific evidence. These Treatment Recommendations, presented here in final form for the first time, are based on exhaustive reviews of the treatment outcomes literature (previously published in Schizophrenia Bulletin, Vol. 21, No. 4, 1995) and focus on those treatments for which there is substantial evidence of efficacy. The recommendations address antipsychotic agents, adjunctive pharmacotherapies, electroconvulsive therapy, psychological interventions, family interventions, vocational rehabilitation, and assertive community treatment/intensive case management. Support for each recommendation is referenced to the previous PORT literature reviews, and the recommendations are rated according to the level of supporting evidence. The PORT Treatment Recommendations provide a basis for moving toward "evidence-based" practice for schizophrenia and identify both the strengths and limitations in our current knowledge base.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.schbul.a033302

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021
Family Interventions for Schizophrenia
Dixon, L. B., & Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.631 · Cited by 394
Self-citation
Psychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 271
Vocational Rehabilitation in Shizophrenia
Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.645 · Cited by 239
Self-citation
Assertive Community Treatment and Case Management for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.657 · Cited by 226
Conventional Antipsychotic Medications for Schizophrenia
Dixon, L. B., Lehman, A. F., & Levine, J. A. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.567 · Cited by 182
Self-citation
Clozapine: Efficacy and Safety
Buchanan, R. W. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.579 · Cited by 161
Psychological Interventions for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.621 · Cited by 134
Risperidone: Efficacy and Safety
Umbricht, D., & Kane, J. M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.593 · Cited by 73

Show all 14 references

Research works printed but not linked: 4

Kane, J.M. Schizophrenia. New England Journal of Medicine, 334:34-41, 1996.
Kane, J.M., and Marder, S.R. Psychopharmacologic treat- ment of schizophrenia. Schizophrenia Bulletin, 19(2): 287-302, 1993.
Lehman, A.F. Vocational rehabilitation in schizophrenia. Schizophrenia Bulletin, 21(4):645-656, 1995.
Zito, J.M. Psychotherapeutic Drug Manual. 3rd ed. New York, NY: John Wiley & Sons, 1994.

Sorted by citations

Items 201–300 of 900

The Effect of a Managed Behavioral Health Carve-Out on Quality of Carefor Medicaid Patients Diagnosed as Having Schizophrenia
Busch, A. B., Frank, R. G., & Lehman, A. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.442 · Cited by 63
Self-citation
Mental health professional support in families with a member suffering from severe mental illness: a grounded theory model
Gavois, H., Paulsson, G., & Fridlund, B. (2006) · Scandinavian Journal of Caring Sciences · doi:10.1111/j.1471-6712.2006.00380.x · Cited by 63
Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis
Chouinard, V., Henderson, D. C., Man, C. D., Valeri, L., Gray, B. E., Ryan, K. P., Cypess, A. M., Cobelli, C., Cohen, B. M., & Öngür, D. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0045-1 · Cited by 62
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long‐term worsening
Goetz, C. G., Fan, W., & Leurgans, S. E. (2008) · Movement Disorders · doi:10.1002/mds.22132 · Cited by 61
The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up
Fernandez, H. H., Krupp, B. H., & Friedman, J. H. (2001) · Neurology · doi:10.1212/wnl.56.6.805 · Cited by 61
Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison
Roh, D. D., Chang, J.-G., Kim, C., Cho, H. S., An, S. K., & Jung, Y. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413488221 · Cited by 61
Clinical Profile of an Atypical Antipsychotic: Risperidone
Davis, J. M., & Chen, N. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006925 · Cited by 61
Predicting antipsychotic drug response – Replication and extension to six weeks in an international olanzapine study
Leucht, S., Shamsi, S. A. R., Busch, R. M., Kissling, W., & Kane, J. M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.018 · Cited by 60
Incidence of Deep Vein Thrombosis in Restrained Psychiatric Patients
Ishida, T., Katagiri, T., Uchida, H., Takeuchi, H., Sakurai, H., Watanabe, K., & Mimura, M. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.04.001 · Cited by 60
What is evidence?
Drake, R. E., Latimer, E. A., Leff, H. S., McHugo, G. J., & Burns, B. J. (2004) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2004.05.005 · Cited by 60
Olanzapine
Foster, R. H., & Goa, K. L. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915060-00008 · Cited by 60
Auditory hallucinations in a cross-diagnostic sample of psychotic disorder patients: a descriptive, cross-sectional study
Shinn, A. K., Pfaff, D. L., Young, S., Lewandowski, K. E., Cohen, B. M., & Öngür, D. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.11.003 · Cited by 58
A Review of Interventions to Reduce the Prevalence of Parasuicide
Comtois, K. A. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.9.1138 · Cited by 58
Psychosocial treatment approaches for schizophrenia
Mueser, K. T., & Bond, G. R. (2000) · Current Opinion in Psychiatry · doi:10.1097/00001504-200001000-00006 · Cited by 58
Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021
Santomauro, D. F., Vos, T., Whiteford, H. A., Chisholm, D., Saxena, S., & Ferrari, A. J. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00317-1 · Cited by 57
The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis
Carrà, G., Bartoli, F., Carretta, D., Crocamo, C., Bozzetti, A., Clerici, M., & Bebbington, P. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0835-y · Cited by 58
Racial Disparities in Mental Health Outcomes after Psychiatric Hospital Discharge among Individuals with Severe Mental Illness
Eack, S. M., & Newhill, C. E. (2012) · Social Work Research · doi:10.1093/swr/svs014 · Cited by 57
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review
Buoli, M., Serati, M., & Altamura, A. C. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.08.024 · Cited by 59
Treatment of the psychotic patient who is violent
Buckley, P. F., Noffsinger, S., Smith, D. A., Hrouda, D. R., & Knoll, J. L. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00029-1 · Cited by 57
Reduction of Symptoms by Valacyclovir in Cytomegalovirus-Seropositive Individuals With Schizophrenia
Dickerson, F., Boronow, J. J., Stallings, C. R., Origoni, A. E., & Yolken, R. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2234 · Cited by 57
Pharmacological long-term treatment strategies in first episode schizophrenia
Gäebel, W., Möller, H., Buchkremer, G., Ohmann, C., Riesbeck, M., Wölwer, W., von Wilmsdorff, M., Bottlender, R., & Klingberg, S. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0509-y · Cited by 57
A Web-Based Program to Empower Patients Who Have Schizophrenia to Discuss Quality of Care With Mental Health Providers
Steinwachs, D. M., ROTER, D. L., Skinner, E. A., Lehman, A. F., Fahey, M., Cullen, B., Everett, A. S., & Gallucci, G. (2011) · Psychiatric Services · doi:10.1176/ps.62.11.pss6211_1296 · Cited by 56
Self-citation
Promoting the Implementation of Practices that are Supported by Research: The National Implementing Evidence-Based Practice Project
Torrey, W. C., Lynde, D., & Gorman, P. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2004.05.004 · Cited by 56
Integration of Care: Integrated Treatment of Schizophrenia
Lenroot, R., Bustillo, J., Lauriello, J., & Keith, S. J. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.11.1499 · Cited by 56
Programma 2000: Celebrating 10 Years of Activity of an Italian Pilot Programme on Early Intervention in Psychosis
Cocchi, A., Meneghelli, A., & Preti, A. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802512032 · Cited by 55
Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors
Bahorik, A. L., Newhill, C. E., Queen, C., & Eack, S. M. (2013) · Psychological Medicine · doi:10.1017/s0033291713000548 · Cited by 55
Computers will become increasingly important for psychological assessment: Not that there's anything wrong with that.
Garb, H. N. (2000) · Psychological Assessment · doi:10.1037//1040-3590.12.1.31 · Cited by 55
High‐dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies
Sim, K., Su, H. C., Fujii, S., Yang, S., Chong, M., Ungvari, G., Si, T., He, Y. L., Chung, E. K., Chan, Y. H., et al. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03304.x · Cited by 54
Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
Yue, Y., Kong, L., Wang, J., Li, C., Tan, L., Su, H. L., & Xu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147204 · Cited by 54
The recognition and optimal management of early psychosis: an evidence-based reform.
McGorry, P. D. (2002) · Europe PMC (PubMed Central) · Cited by 54
Evidence-based Psychosocial Treatment Practices in Schizophrenia: Lessons from the Patient Outcomes Research Team (PORT) Project
Lehman, A. F., & Steinwachs, D. M. (2003) · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry · doi:10.1521/jaap.31.1.141.21939 · Cited by 54
Self-citation
Open Forum: Effectiveness Versus Efficacy of Second-Generation Antipsychotics: Haloperidol Without Anticholinergics as a Comparator
Rosenheck, R. A. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.1.85 · Cited by 54
Multiple Antipsychotic Medication Prescribing Patterns
Schumacher, J. E., Makela, E. H., & Griffin, H. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c420 · Cited by 54
EQUIP: implementing chronic care principles and applying formative evaluation methods to improve care for schizophrenia: QUERI Series.
Brown, A. H., Cohen, A. N., Chinman, M. J., Kessler, C., & Young, A. S. (2008) · Implementation Science · doi:10.1186/1748-5908-3-9 · Cited by 53
An Instrument to Assess Competencies of Providers Treating Severe Mental Illness
Chinman, M., Young, A. S., Rowe, M., Forquer, S., Knight, E., & Miller, A. (2003) · Mental Health Services Research · doi:10.1023/a:1023281527952 · Cited by 53
Gaps in Use of Antipsychotics After Discharge by First-Admission Patients With Schizophrenia, 1989 to 1996
Mojtabai, R., Lavelle, J., Gibson, P. J., Sohler, N., Craig, T., Carlson, G. A., & Bromet, E. J. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.3.337 · Cited by 53
The therapeutic alliance and family psychoeducation in the treatment of schizophrenia: An exploratory prospective change process study.
Smerud, P. E., & Rosenfarb, I. S. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.3.505 · Cited by 52
Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics
Gianfrancesco, F. D., Rajagopalan, K., Sajatovic, M., & Wang, R. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2006.02.006 · Cited by 52
Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys
Borges, G. L. G., Aguilar‐Gaxiola, S., Andrade, L. H., Benjet, C. L., Cía, A. H., Kessler, R. C., Orozco, R., Sampson, N. A., Stagnaro, J. C., Torres, Y., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000477 · Cited by 56
Pharmacogenetic Testing in the Clinical Management of Schizophrenia
Perlis, R. H., Ganz, D. A., Avorn, J., Schneeweiß, S., Glynn, R. J., Smoller, J. W., & Wang, P. S. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000177553.59455.24 · Cited by 52
Predicting Drug-Free Treatment Response in Acute Psychosis From the Soteria Project
Bola, J. R., & Mosher, L. R. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006964 · Cited by 52
Releasing Information to Families of Persons With Severe Mental Illness: A Survey of NAMI Members
Marshall, T., & Solomon, P. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.8.1006 · Cited by 51
Sex, ethnicity, and antipsychotic medication use in patients with psychosis
Arnold, L. M., Strakowski, S. M., Schwiers, M., Amicone, J., Fleck, D. E., Corey, K. B., & Farrow, J. E. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00102-6 · Cited by 51
Best Practices: New York State's Campaign to Implement Evidence-Based Practices for People With Serious Mental Disorders
Carpinello, S. E., Rosenberg, L., Stone, J., Schwager, M., & Felton, C. J. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.2.153 · Cited by 51
Evidence-based treatment for schizophrenia
Lehman, A. F., Buchanan, R. W., Dickerson, F., Dixon, L. B., Goldberg, R. W., Green-Paden, L. D., & Kreyenbuhl, J. A. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00070-4 · Cited by 51
Self-citation
Guideline Recommendations for Treatment of Schizophrenia
Dickey, B., Normand, S. T., Hermann, R. C., Eisen, S. V., Cortés, D. E., Cleary, P. D., & Ware, N. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.340 · Cited by 51
Evidence-Based Psychosocial Treatment for Schizophrenia
Fenton, W. S., & Schooler, N. R. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033428 · Cited by 51
Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia
Lin, J., Wong, B., Offord, S. J., & Mirski, D. F. (2013) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-013-9329-z · Cited by 50
Transcending the Actuarial Versus Clinical Polemic in Assessing Risk for Violence
Webster, C. D., Hucker, S. J., & Bloom, H. (2002) · Criminal Justice and Behavior · doi:10.1177/009385402236736 · Cited by 50
Rehospitalization Risk with Second-Generation and Depot Antipsychotics
Conley, R. R., Kelly, D. L., Love, R. C., & McMahon, R. P. (2003) · Annals of Clinical Psychiatry · doi:10.1023/a:1023276509470 · Cited by 50
Risperidone versus Conventional Antipsychotics for Schizophrenia and???Schizoaffective Disorder
Mahmoud, R. A., Engelhart, L., Janagap, C. C., Oster, G., & Ollendorf, D. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424050-00004 · Cited by 50
Performance Measures for Early Psychosis Treatment Services
Addington, D. E., McKenzie, E., Addington, J., Patten, S. B., Smith, H., & Adair, C. E. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.12.1570 · Cited by 56
The Impact of Olanzapine, Risperidone, or Haloperidol on the Cost of Schizophrenia Care in a Medicaid Population
Gibson, P. J., Damler, R., Jackson, E. A., Wilder, T., & Ramsey, J. L. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.71272.x · Cited by 50
Dimensions of supported employment: Factor structure of the IPS fidelity scale
Bond, G. R., Vogler, K. M., Resnick, S. G., Evans, L. J., Drake, R. E., & Becker, D. R. (2001) · Journal of Mental Health · doi:10.1080/09638230124258 · Cited by 50
Geriatric Mental Health Services Research: Strategic Plan for an Aging Population: Report of the Health Services Work Group of the American Association for Geriatric Psychiatry
Soo Borson, B., Bartels, S. J., Colenda, C. C., Gottlieb, G. L., & Meyers, B. S. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200108000-00002 · Cited by 50
Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia
Horst, W. D., Klein, M. W., Williams, D. D., & Werder, S. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a802 · Cited by 49
Attitudes and Perceived Barriers to Working with Families of Persons with Severe Mental Illness: Mental Health Professionals’ Perspectives
Kim, H., & Salyers, M. P. (2008) · Community Mental Health Journal · doi:10.1007/s10597-008-9135-x · Cited by 49
Improving Quality And Diffusing Best Practices: The Case Of Schizophrenia
Horvitz-Lennon, M. V., Donohue, J. M., Domino, M. E., & Normand, S. T. (2009) · Health Affairs · doi:10.1377/hlthaff.28.3.701 · Cited by 49
Developing services for first-episode psychosis and the critical period
Edwards, J., Harris, M., & Bapat, S. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.48.s91 · Cited by 49
The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients
Go, C. L., Rosales, R. L., Caraos, R. J., & Fernandez, H. H. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.015 · Cited by 48
Measuring Continuity of Care for Clients of Public Mental Health Systems
Fortney, J. C., Sullivan, G., Williams, K., Jackson, C. M., Morton, S. C., & Koegel, P. (2003) · Health Services Research · doi:10.1111/1475-6773.00168 · Cited by 47
Comparison of Clozapine Use in Maryland and in Victoria, Australia
Conley, R. R., Kelly, D. L., Lambert, T. J. R., & Love, R. C. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.3.320 · Cited by 47
Family intervention for Asian Americans with a schizophrenic patient in the family.
Bae, S., & Kung, W. W. (2000) · American Journal of Orthopsychiatry · doi:10.1037/h0087789 · Cited by 47
Changes Over Time and Disparities in Schizophrenia Treatment Quality
Busch, A. B., Lehman, A. F., Goldman, H. H., & Frank, R. G. (2009) · Medical Care · doi:10.1097/mlr.0b013e31818475b7 · Cited by 47
Self-citation
Assessing the Value of Antipsychotics for Treating Schizophrenia
Tunis, S. L., Ascher‐Svanum, H., Stensland, M. D., & Kinon, B. J. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422010-00001 · Cited by 47
Premorbid, psychosocial and clinical predictors of the costs of schizophrenia and other psychoses
Carr, V. J., Lewin, T. J., Neil, A. L., Halpin, S. A., & Holmes, S. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.6.517 · Cited by 46
Techniques Used by Assertive Community Treatment (ACT) Teams to Encourage Adherence: Patient and Staff Perceptions
Appelbaum, P. S., & Melle, S. M. L. (2008) · Community Mental Health Journal · doi:10.1007/s10597-008-9149-4 · Cited by 46
Perceived Benefits and Difficulties Experienced in a Mutual Support Group for Family Carers of People With Schizophrenia
Chien, W. T., Norman, I. J., & Thompson, D. R. (2006) · Qualitative Health Research · doi:10.1177/1049732306290140 · Cited by 46
Competencies for direct service staff members who work with adults with severe mental illnesses in outpatient public mental health/managed care systems.
Coursey, R. D., Initiative, A. P. O. T. M. C., Curtis, L. C., Marsh, D. T., Campbell, J., Harding, C. M., Spaniol, L., Lucksted, A. A., McKenna, J. W., Kelley, M. J., et al. (2000) · Psychiatric Rehabilitation Journal · doi:10.1037/h0095141 · Cited by 46
State of the Art of Drug Treatment of Schizophrenia and the Future Position of the Novel/Atypical Antipsychotics
Möller, H. ‐. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150593 · Cited by 46
Multifamily Group Psychoeducation and Cognitive Remediation for First-Episode Psychosis: A Randomized Controlled Trial
Breitborde, N. J., Moreno, F. A., Mai-Dixon, N., Peterson, R., Durst, L., Bernstein, B., Byreddy, S., & McFarlane, W. R. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-9 · Cited by 45
Measuring Quality of Pharmacotherapy for Depression in a National Health Care System
Busch, S. H., LESLIE, D. L., & Rosenheck, R. A. (2004) · Medical Care · doi:10.1097/01.mlr.0000128000.96869.1e · Cited by 45
Cognitive schema and naturalistic decision making in evidence-based practices
Falzer, P. R. (2004) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2004.02.002 · Cited by 47
Strategies for leading the implementation of evidence-based practices
Torrey, W. C., Finnerty, M. T., Evans, A. C., & Wyzik, P. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00067-4 · Cited by 45
Convergent Evidence from Multimodal Imaging Reveals Amygdala Abnormalities in Schizophrenic Patients and Their First-Degree Relatives
Tian, L., Meng, C., Yan, H., Zhao, Q., Liu, Q., Yan, J., Han, Y., Yuan, H., Wang, L., Yue, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028794 · Cited by 44
Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period
Edlinger, M., Hausmann, A., Kemmler, G., Kurz, M., Kurzthaler, I., Walch, T., Walpoth, M., & Fleischhacker, W. W. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.01.015 · Cited by 44
Racial/Ethnic Disparities in Mental Health Treatment in Six Medicaid Programs
Samnaliev, M., McGovern, M. P., & Clark, R. E. (2009) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.0.0125 · Cited by 44
Toward a national consumer survey: Evaluation of the CABHS and MHSIP instruments
Eisen, S. V., Shaul, J. A., Leff, H. S., Stringfellow, V. L., Clarridge, B. R., & Cleary, P. D. (2001) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287249 · Cited by 44
Implementing Psychoeducational Interventions in Italy for Patients With Schizophrenia and Their Families
Magliano, L., Fiorillo, A., Malangone, C., Rosa, C. D., Maj, M., & the Family Intervention Working Group (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.2.266 · Cited by 44
Use and Costs of Ambulatory Care Services Among Medicare Enrollees With Schizophrenia
Dixon, L. B., Lyles, A., Smith, C., Hoch, J. S., Fahey, M., Postrado, L. T., Lucksted, A. A., & Lehman, A. F. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.6.786 · Cited by 44
Self-citation
Psychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia
Glick, I. D., Suppes, T. M., DeBattista, C., Hu, R. J., & Marder, S. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00013 · Cited by 44
The Development of a Culturally Informed, Family‐Focused Treatment for Schizophrenia
de Mamani, A. W., Duarte, E. A., Koneru, V. K., & Wasserman, S. (2006) · Family Process · doi:10.1111/j.1545-5300.2006.00089.x · Cited by 43
Stages in the Implementation of Innovative Clinical Programs in Complex Organizations
Rosenheck, R. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200112000-00002 · Cited by 43
Assessing Cost-Effectiveness in Mental Health: Family Interventions for Schizophrenia and Related Conditions
Mihalopoulos, C., Mihalopoulos, C., Magnus, A., Carter, R., & Vos, T. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01404.x · Cited by 43
Fundamental principles of evidence-based medicine applied to mental health care
Drake, R. E., Rosenberg, S. D., Teague, G. B., Bartels, S. J., & Torrey, W. C. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00063-7 · Cited by 43
An RCT With Three-Year Follow-Up of Peer Support Groups for Chinese Families of Persons With Schizophrenia
Chien, W. T., & Thompson, D. R. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200243 · Cited by 42
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines
Fountoulakis, K. Ν., Young, A. H., Yatham, L. N., Grunze, H., Vieta, E., Blier, P., Moeller, H. J., & Kasper, S. F. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw091 · Cited by 42
Therapists' Contacts With Family Members of Persons With Severe Mental Illness in a Community Treatment Program
Dixon, L. B., Lucksted, A. A., Stewart, B., & Delahanty, J. C. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.11.1449 · Cited by 42
The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study
Hayhurst, K. P., Brown, P., & Lewis, S. W. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600208 · Cited by 42
Course Patterns of Psychosocial Functioning in Schizophrenia Patients Attending a Vocational Rehabilitation Program
Kupper, Z., & Hoffmann, H. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033486 · Cited by 42
Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock, D. L., Zhao, Z., Johnstone, B. M., & Morris, L. S. (2003) · PubMed · Cited by 41
Integrative Circuit Models and Their Implications for the Pathophysiologies and Treatments of the Schizophrenias
Swerdlow, N. R. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_48 · Cited by 41
Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
Edwards, N. C., Rupnow, M. F. T., Pashos, C. L., Botteman, M. F., & Diamond, R. J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523030-00009 · Cited by 41
Psychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric network
Aguglia, E., Pascolo‐Fabrici, E., Bertossi, F., & Bassi, M. (2007) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-3-7 · Cited by 42
The Role of Attention in Affect Perception: An Examination of Mirsky's Four Factor Model of Attention in Chronic Schizophrenia
Combs, D. R., & Gouvier, W. D. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007126 · Cited by 41
Implementing Research Findings into Practice Using Clinical Opinion Leaders: Barriers and Lessons Learned
Curran, G. M., Thrush, C. R., Smith, J. L., Owen, R. R., Ritchie, M. J., & Chadwick, D. (2005) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(05)31091-9 · Cited by 41
Antipsychotic Prescribing Practices
Essock, S. M. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006911 · Cited by 41
Antipsychotic medication for early episode schizophrenia
Bola, J. R., Kao, D., Soydan, H., & Adams, C. E. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006374.pub2 · Cited by 43
Entwicklungsprozess der DGPPN-Qualitätsindikatoren
Großimlinghaus, I., Falkai, P., Gäebel, W., Janssen, B., Reich‐Erkelenz, D., Wobrock, T., & Zielasek, J. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3705-4 · Cited by 40
Challenges to Implementing and Sustaining Comprehensive Mental Health Service Programs
Gold, P. B., Glynn, S. M., & Mueser, K. T. (2006) · Evaluation & the Health Professions · doi:10.1177/0163278706287345 · Cited by 40

Authors: Lehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project
Affiliations: University of Maryland, Baltimore (US)
Johns Hopkins University (US)
Corresponding author: Lehman, A. F.
Venue: Schizophrenia Bulletin
Publisher: Oxford University Press (OUP)
Published: 1998-01-01
Volume: 24
Issue: 1
Pages: 1-10
ISSN: 0586-7614 (ISSN-L)
1745-1701
DOI: 10.1093/oxfordjournals.schbul.a033302
OpenAlex: W2121113553
Cited by: 910
References: 14
Citations by year: 2025: 6 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 8 · 2019: 12 · 2018: 23 · 2017: 12 · 2016: 17 · 2015: 14 · 2014: 16 · 2013: 22 · 2012: 41
FWCI: 38.90
Type: journal article
Language: en
Open access: closed
Locations: Schizophrenia Bulletin (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: schizophrenia
MeSH terms: Combined Modality Therapy, Health Policy, Humans, Research Support as Topic, Schizophrenia, United States, United States Agency for Healthcare Research and Quality, Treatment Outcome, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks